Anileridine

Jump to: navigation, search
Anileridine
Anileridine.png
Clinical data
AHFS/Drugs.comMonograph
Routes of
administration
Tablets, injection
ATC code
Legal status
Legal status
Pharmacokinetic data
Protein binding> 95%
MetabolismHepatic
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC22H28N2O2
Molar mass352.47 g/mol
3D model (JSmol)
Melting point83 °C (181.4 °F)
 ☒N☑Y (what is this?)  (verify)

WikiDoc Resources for Anileridine

Articles

Most recent articles on Anileridine

Most cited articles on Anileridine

Review articles on Anileridine

Articles on Anileridine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Anileridine

Images of Anileridine

Photos of Anileridine

Podcasts & MP3s on Anileridine

Videos on Anileridine

Evidence Based Medicine

Cochrane Collaboration on Anileridine

Bandolier on Anileridine

TRIP on Anileridine

Clinical Trials

Ongoing Trials on Anileridine at Clinical Trials.gov

Trial results on Anileridine

Clinical Trials on Anileridine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Anileridine

NICE Guidance on Anileridine

NHS PRODIGY Guidance

FDA on Anileridine

CDC on Anileridine

Books

Books on Anileridine

News

Anileridine in the news

Be alerted to news on Anileridine

News trends on Anileridine

Commentary

Blogs on Anileridine

Definitions

Definitions of Anileridine

Patient Resources / Community

Patient resources on Anileridine

Discussion groups on Anileridine

Patient Handouts on Anileridine

Directions to Hospitals Treating Anileridine

Risk calculators and risk factors for Anileridine

Healthcare Provider Resources

Symptoms of Anileridine

Causes & Risk Factors for Anileridine

Diagnostic studies for Anileridine

Treatment of Anileridine

Continuing Medical Education (CME)

CME Programs on Anileridine

International

Anileridine en Espanol

Anileridine en Francais

Business

Anileridine in the Marketplace

Patents on Anileridine

Experimental / Informatics

List of terms related to Anileridine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Anileridine (trade name: Leritine) is a synthetic analgesic drug and is a member of the piperidine class of analgesic agents developed by Merck & Co. in the 1950s. It differs from pethidine (meperidine) in that the N-methyl group of meperidine is replaced by an N-aminophenethyl group, which increases its analgesic activity.

Anileridine is no longer manufactured in the US or Canada.[1]

Administration

As tablets or injection.[2]

Pharmacokinetics

Anileridine usually takes effect within 15 minutes of either oral or intravenous administration, and lasts 2–3 hours.[3] It is mostly metabolized by the liver.

References

  1. "Discontinued Prescription Drug Products". Canadian Pharmacists' Association. Retrieved 28 July 2008.
  2. "Pharmaceutical Information - LERITINE". RxMed. Retrieved 16 June 2010.
  3. "Anileridine Consumer Information". MedicineNet. Retrieved 28 July 2008.

Linked-in.jpg